• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative in vitro activity of BAY Y 3118 against selected species.

作者信息

Verbist L, Verhaegen J

机构信息

Department of Bacteriology, University Hospital St Rafaël, Leuven, Belgium.

出版信息

Drugs. 1995;49 Suppl 2:264-5. doi: 10.2165/00003495-199500492-00064.

DOI:10.2165/00003495-199500492-00064
PMID:8549326
Abstract
摘要

相似文献

1
Comparative in vitro activity of BAY Y 3118 against selected species.
Drugs. 1995;49 Suppl 2:264-5. doi: 10.2165/00003495-199500492-00064.
2
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.BAY Y 3118与其他氟喹诺酮类药物的体外活性比较
Drugs. 1995;49 Suppl 2:222-5. doi: 10.2165/00003495-199500492-00048.
3
In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.新型二氟喹诺酮洛美沙星对尿液细菌分离株的体外活性：与依诺沙星和氧氟沙星的比较。
J Chemother. 1989 Jul;1(4 Suppl):176-7.
4
Comparative in vitro activities of new quinolones against coryneform bacteria.新型喹诺酮类药物对棒状杆菌的体外活性比较
Antimicrob Agents Chemother. 1994 Jun;38(6):1439-41. doi: 10.1128/AAC.38.6.1439.
5
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.从慢性中耳炎和慢性鼻窦炎分离出的细菌菌株对环丙沙星的体外敏感性。
Drugs. 1995;49 Suppl 2:200-2. doi: 10.2165/00003495-199500492-00041.
6
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.司帕沙星与环丙沙星及氧氟沙星相比对呼吸道病原体的体外活性。
Chemotherapy. 1993;39(1):32-5. doi: 10.1159/000238970.
7
A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.氟罗沙星与其他三种喹诺酮类药物体外活性比较的多中心研究：来自27个中心的中期报告
Am J Med. 1993 Mar 22;94(3A):2S-8S.
8
The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.新型4-喹诺酮类药物DU-6859a和DV-7751a对肺炎链球菌显示出增强的活性。
Drugs. 1995;49 Suppl 2:228-9. doi: 10.2165/00003495-199500492-00050.
9
[The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].[Maxaquin（盐酸洛美沙星）在治疗非特异性炎症性疾病及预防泌尿外科手术干预中的应用]
Urol Nefrol (Mosk). 1998 Sep-Oct(5):14-8.
10
In vitro activity of MF 5137, a new potent 6-aminoquinolone.新型强效6-氨基喹诺酮类药物MF 5137的体外活性
Drugs. 1995;49 Suppl 2:272-3. doi: 10.2165/00003495-199500492-00067.

本文引用的文献

1
In vitro activity of Bay y 3118, a new quinolone.新型喹诺酮类药物Bay y 3118的体外活性
Antimicrob Agents Chemother. 1993 Nov;37(11):2348-57. doi: 10.1128/AAC.37.11.2348.
2
In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.BAY Y3118、环丙沙星、氧氟沙星和氟罗沙星对呼吸道及软组织感染的革兰氏阳性和革兰氏阴性病原体的体外活性。
Antimicrob Agents Chemother. 1993 Sep;37(9):2017-9. doi: 10.1128/AAC.37.9.2017.